FDA Recalls Ipratropium Bromide Inhalation Solution Due to Manufacturing Deviation
McKesson Medical-Surgical is recalling Ipratropium Bromide Inhalation Solution nationwide due to current good manufacturing practice (cGMP) deviations involving temperature control. The FDA has classified this as a Class II recall.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving manufacturing deviations. However, no illnesses, injuries, or hospitalizations have been reported. The hazard is based on a manufacturing control issue (temperature deviation) rather than confirmed product defect or contamination, warranting a High severity rating.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL. This prescription respiratory medication is packaged in 25-count boxes of sterile unit-dose vials and was manufactured by Nephron Pharmaceuticals Corporation.
The recall was initiated because of current good manufacturing practice (cGMP) deviations related to temperature control during manufacturing. McKesson Medical-Surgical was unable to identify which specific lot numbers were received by individual customers; distribution letters included the dates of distribution and the dates when affected product may have been shipped.
Approximately 57 pouches of the recalled product were distributed across the United States. Healthcare providers and patients who have this medication should contact their pharmacy for guidance.
The recalled product
- Product
- IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
- Brand
- IPRATROPIUM BROMIDE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Inhalation solution
- Affected units
- 57
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (2)
- 0304879801011
- 0304879801004
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · manufacturing deviation
See all →- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06